OS 10-03 THE DISTINCTIVE EFFECT OF POLYSACCHARIDE PEPTIDES GANODERMA LUCIDUM AS ANTI ATHEROGENESIS IN STABLE ANGINA PATIENTS

OS 10-03 THE DISTINCTIVE EFFECT OF POLYSACCHARIDE PEPTIDES GANODERMA LUCIDUM AS ANTI ATHEROGENESIS IN STABLE ANGINA PATIENTS

OBJECTIVE:This study was aimed to evaluate the effects of polysaccharide peptides (PsP) of Ganoderma lucidum as anti inflammation, anti oxidant, anti diabetic and anti lipid in stable angina pectoris patients. DESIGN AND METHOD:This is a quasi clinical trial experimental study on 34 Stable Angina pa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hypertension Vol. 34 Suppl 1 - ISH 2016 Abstract Book; no. Supplement 1; p. e72
Main Authors: Ubaidillah, Nizamuddin, Sargowo, Djanggan, Widya, Adriawan, Jakfar, Vitryaturrida, Proboretno, Kartika Siwi, Failasufi, Mirza, Warahugraha, Yoga, Ramadhan, Fadli, Wulandari, Hesti, Putri, Dinarsari Hayuning
Format: Journal Article
Language:English
Published: Copyright Wolters Kluwer Health, Inc. All rights reserved 01-09-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVE:This study was aimed to evaluate the effects of polysaccharide peptides (PsP) of Ganoderma lucidum as anti inflammation, anti oxidant, anti diabetic and anti lipid in stable angina pectoris patients. DESIGN AND METHOD:This is a quasi clinical trial experimental study on 34 Stable Angina patients in Saiful Anwar General Hospital was determined based on ESC Stable CAD guidelines, with pre-test and post-test design without control. Parameter measured were TNF alfa, IL-6, MDA, SOD, HbA1c, Fasting glucose and Total cholesterol. The patients were given PsP 750 mg/day in divided dose for 90 days, while continuing the previous medications as directed by guidelines. The data was analyzed by paired t-test for parametric data and Wilcoxon test for non-parametric data. RESULTS:After PSP administration we found significantly reduce the level of TNF alfa level from 11444 ± 2352.70 to 476.13 ± 482.99 (p = 0.000), IL-6 level from 294.70 ± 123.28 to 24.41 ± 21.45 (p = 0.000), MDA level from 95.63 ± 21.27 to 44,84 ± 50,95 (p = 0.000), increased SOD level from 3.41 ± 0,46 to 5,97 ± 4,19, HbA1c from 6.59 ± 3.05 to 5.62 ± 1.41 (p = 0.009), fasting glucose level reduced from 113.08 ± 12.44 mg/dl to 97.95 ± 6.22 mg/dl (p = 0.342) and total cholesterol level reduced from 205,49 ± 48,49 mg/dl to 182,11 ± 73,81 mg/dl (p = 0.081). CONCLUSIONS:Ganoderma lucidum polysaccharide peptides have distinctive effect on anti inflammation, anti oxidant, anti diabetic and anti lipid in stable angina pectoris and promising as additional drug in the treatment of coronary artery disease caused by atherosclerotic process.
ISSN:0263-6352
1473-5598
DOI:10.1097/01.hjh.0000500039.08261.4f